What we do
Over the last 17 years we have participated in some of the most renowned clinical development programs in the fields of psychiatry and neurology – helping to bring some of the leading medicines to market.
Neuroscience CRO Expert
Sites that we have chosen, activated and managed have also been instrumental in rescuing recruitment targets for globally significant trials, including challenging paediatric indications.
Our therapeutic area experience includes the following indications: Alzheimer’s Disease; Bipolar Disorder; Major Depression; Multiple Sclerosis; Schizophrenia; Paediatric Schizophrenia & Bipolar Disorder.
We have established collaborative site relationships with excellent recruitment potential.
50+ Studies conducted
61% of Phase II and Phase III
Close collaboration with
150 sites
10+ studies
in Multiple Sclerosis conducted in the last five years
15+ indications
Optimapharm’s top 5 neurology indications.
Staff experience
166 staff members with neurology projects experience
